Alendronate in postmenopausal osteoporosis
- PMID: 8594442
Alendronate in postmenopausal osteoporosis
Comment on
-
Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.N Engl J Med. 1995 Nov 30;333(22):1437-43. doi: 10.1056/NEJM199511303332201. N Engl J Med. 1995. PMID: 7477143 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical